Clinical Trial Update: 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing 24-hour efficacy and tolerability of tafluprost-timolol fixed combination without preservatives in glaucomatous or ocular hypertensive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• tafluprost-timolol fixed combination (tafluprost-timolol)

Snippet

Sponsor: Fondazione G.B. Bietti, IRCCS | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: UNKNOWN